Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical evaluation of natalizumab for formulary consideration.
Bivins A, Hou K, Ayesu N, Ellsworth B Jr, Montenegro S, Tu X, Boyle C, Dowling T, Shaya FT. Bivins A, et al. Among authors: montenegro s. Expert Opin Biol Ther. 2010 Aug;10(8):1279-87. doi: 10.1517/14712598.2010.505234. Expert Opin Biol Ther. 2010. PMID: 20626228 Review.
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510).
Montenegro S, Helwig C, Schwarze JE, Castello-Bridoux C, Marque S, Lispi M, D'Hooghe T. Montenegro S, et al. J Gynecol Obstet Hum Reprod. 2023 Oct;52(8):102640. doi: 10.1016/j.jogoh.2023.102640. Epub 2023 Aug 6. J Gynecol Obstet Hum Reprod. 2023. PMID: 37549879 No abstract available.
Lipidomics Profile Change of Skin Surface Lipids in Nummular Eczema.
Oh JH, Lee H, Montenegro SE, Jin SP, Chung JH. Oh JH, et al. Among authors: montenegro se. J Invest Dermatol. 2023 May;143(5):864-867.e9. doi: 10.1016/j.jid.2022.10.010. Epub 2022 Oct 29. J Invest Dermatol. 2023. PMID: 37306380 Free article. No abstract available.
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.
Rodenas MC, Peñas-Martínez J, Pardo-Sánchez I, Zaragoza-Huesca D, Ortega-Sabater C, Peña-García J, Espín S, Ricote G, Montenegro S, Ayala-De La Peña F, Luengo-Gil G, Nieto A, García-Molina F, Vicente V, Bernardi F, Lozano ML, Mulero V, Pérez-Sánchez H, Carmona-Bayonas A, Martínez-Martínez I. Rodenas MC, et al. Among authors: montenegro s. Front Mol Biosci. 2023 May 19;10:1182925. doi: 10.3389/fmolb.2023.1182925. eCollection 2023. Front Mol Biosci. 2023. PMID: 37275957 Free PMC article.
152 results